CMV STAT
Echnacea (angustifolia), Hydrastis canadensis, Lomatium dissectum, Phytolacca decandra, Tabebuia impetiginosa, Aranea diadema, Ipecacuanha, Iridium metallicum, Lachesis mutus, Muriaticum acidum, Rhox tox, Epstein-barr virus nosode,
36 matching records for CMV.
Echnacea (angustifolia), Hydrastis canadensis, Lomatium dissectum, Phytolacca decandra, Tabebuia impetiginosa, Aranea diadema, Ipecacuanha, Iridium metallicum, Lachesis mutus, Muriaticum acidum, Rhox tox, Epstein-barr virus nosode,
Echinacea (Angustifolia), Lomatium Dissectum, Tabebuia Impetiginosa, Hydrastis Canadensis, Phytolacca Decandra, Aranea Diadema, Ipecacuanha, Iridium Metallicum, Lachesis Mutus, Muriaticum Acidum, Rhus Tox, Epstein-Barr Virus Nosode
Echinacea (Angustifolia), Lomatium Dissectum, Tabebuia Impetiginosa, Hydrastis Canadensis, Phytolacca Decandra, Aranea Diadema, Ipecacuanha, Iridium Metallicum, Lachesis Mutus, Muriaticum Acidum, Rhus Tox, Cytomegalovirus Nosode
One or multiple immunoglobulins with the capability of binding to specific antigenic determinants intended to be used for the qualitative and/or quantitative detection of antigens from Cytomegalovirus (CMV) in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of nucleic acid from cytomegalovirus (CMV) in a clinical specimen, using a nucleic acid technique (NAT).
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of immunoglobulin G (IgG) antibodies to cytomegalovirus (CMV) in a clinical specimen, using an enzyme immunoassay (EIA) method.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of antigens from cytomegalovirus (CMV) in a clinical specimen, using a fluorescent immunoassay method.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of immunoglobulin M (IgM) antibodies to cytomegalovirus (CMV) in a clinical specimen, using an enzyme immunoassay (EIA) method.
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of antigens from cytomegalovirus (CMV) in a clinical specimen.
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of nucleic acid from cytomegalovirus (CMV) in a clinical specimen.
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of immunoglobulin G (IgG) antibodies to cytomegalovirus (CMV) in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of immunoglobulin G (IgG) antibodies to cytomegalovirus (CMV) in a clinical specimen, using a chemiluminescent immunoassay method.
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of immunoglobulin M (IgM) antibodies to cytomegalovirus (CMV) in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of immunoglobulin M (IgM) antibodies to cytomegalovirus (CMV) in a clinical specimen, using a fluorescent immunoassay method.
A material which is used to establish known points of reference for an assay intended to be used for the qualitative and/or quantitative detection of nucleic acid from cytomegalovirus (CMV) in a clinical specimen.
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of antigens from cytomegalovirus (CMV) in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of immunoglobulin M (IgM) antibodies to cytomegalovirus (CMV) in a clinical specimen, using a chemiluminescent immunoassay method.
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of nucleic acid from cytomegalovirus (CMV) in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of immunoglobulin G (IgG) antibodies to cytomegalovirus (CMV) in a clinical specimen, using a fluorescent immunoassay method.
A collection of reagents and other associated materials intended to be used for the determination of the avidity index of immunoglobulin G (IgG) antibodies to cytomegalovirus (CMV) in a clinical specimen, using a chemiluminescent immunoassay method.
A defined piece of single-stranded nucleic acid used to identify specific complementary-sequence nucleic acid molecules in an assay intended to be used for diagnosing, monitoring or predicting cytomegalovirus (CMV) infection in a clinical specimen.
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of total antibodies to cytomegalovirus (CMV) in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of total antibodies to cytomegalovirus (CMV) in a clinical specimen, using an enzyme immunoassay (EIA) method.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of antigens from cytomegalovirus (CMV) in a clinical specimen, using a direct fluorescent test (DFT).
A material which is used to verify the performance of an assay intended to be used for the determination of the avidity index of immunoglobulin G (IgG) antibodies to cytomegalovirus (CMV) in a clinical specimen.
A material which is used to establish known points of reference for an assay intended to be used for the qualitative and/or quantitative detection of immunoglobulin G (IgG) antibodies to cytomegalovirus (CMV) in a clinical specimen.
A material which is used to establish known points of reference for an assay intended to be used for the qualitative and/or quantitative detection of immunoglobulin M (IgM) antibodies to cytomegalovirus (CMV) in a clinical specimen.
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of immunoglobulin M (IgM) antibodies to cytomegalovirus (CMV) in a clinical spec...
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of total antibodies to cytomegalovirus (CMV) in a clinical specimen.
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of immunoglobulin G (IgG) and/or immunoglobulin M (IgM) antibodies to organisms in a clinical specimen, as part of an antena...
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of reactive T-cells in a clinical specimen which have become activated in response to stimulation by one or multiple specific antig...
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of immunoglobulin G (IgG) and/or immunoglobulin M (IgM) antibodies to organisms in a clinical specimen, as part of an antena...
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of reactive T-cells in a clinical specimen which have become activated in respon...